Journal article
Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey.
- Fraser IS Department of Obstetrics, Gynaecology and Neonatology, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. Electronic address: ian.fraser@sydney.edu.au.
- Mansour D Sexual Health Services, Newcastle Hospitals, Community Health, Newcastle, UK.
- Breymann C Gynecology and Medical Obstetrics, University Hospital Zurich, Switzerland.
- Hoffman C Vifor Pharma, Glattbrugg, Switzerland.
- Mezzacasa A Vifor Pharma, Glattbrugg, Switzerland.
- Petraglia F Obstetrics and Gynecology, University of Siena, Siena, Italy.
- 2015-01-29
Published in:
- International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. - 2015
Anemia
Diagnosis
Heavy menstrual bleeding
Iron deficiency
Prevalence
Adolescent
Adult
Anemia, Iron-Deficiency
Data Collection
Europe
Female
Humans
Internet
Iron
Menorrhagia
Middle Aged
Prevalence
Young Adult
English
OBJECTIVE
To examine the prevalence and impact of heavy menstrual bleeding (HMB) among women in Europe, and their experience of HMB assessment and management.
METHODS
An internet-based survey was conducted among women (aged 18-57 years) in five European countries between January and February 2012. The prevalence of HMB among the general population was determined in a short survey, and women who had been diagnosed with HMB were then asked to complete an extended survey about their diagnosis and symptoms.
RESULTS
Overall, 4506 women responded, of whom 1225 (27.2%) had experienced two or more predefined HMB symptoms within the previous year. Of these women, 564 (46.0%) had never consulted a physician. Among 330 women who completed the detailed survey, 208 (63.0%) had ever been diagnosed with iron deficiency or iron-deficiency anemia. Symptoms associated with iron deficiency were used to help confirm a diagnosis in 83 (39.9%) women. Only 152 (46.1%) of the 330 patients with confirmed HMB had received prescription medication for iron deficiency.
CONCLUSION
Many women affected by HMB do not seek medical help, and few of those who do consult physicians report that they have received appropriate treatment. HMB continues to be underdiagnosed and poorly treated.
To examine the prevalence and impact of heavy menstrual bleeding (HMB) among women in Europe, and their experience of HMB assessment and management.
METHODS
An internet-based survey was conducted among women (aged 18-57 years) in five European countries between January and February 2012. The prevalence of HMB among the general population was determined in a short survey, and women who had been diagnosed with HMB were then asked to complete an extended survey about their diagnosis and symptoms.
RESULTS
Overall, 4506 women responded, of whom 1225 (27.2%) had experienced two or more predefined HMB symptoms within the previous year. Of these women, 564 (46.0%) had never consulted a physician. Among 330 women who completed the detailed survey, 208 (63.0%) had ever been diagnosed with iron deficiency or iron-deficiency anemia. Symptoms associated with iron deficiency were used to help confirm a diagnosis in 83 (39.9%) women. Only 152 (46.1%) of the 330 patients with confirmed HMB had received prescription medication for iron deficiency.
CONCLUSION
Many women affected by HMB do not seek medical help, and few of those who do consult physicians report that they have received appropriate treatment. HMB continues to be underdiagnosed and poorly treated.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1016/j.ijgo.2014.09.027
- PMID 25627706
- Persistent URL
- https://sonar.ch/global/documents/298262
Statistics
Document views: 75
File downloads: